This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Vita Genomics, Inc.. Active years: 2006-2008.
Company Filing History:
Years Active: 2006-2008
Title: Kuang-Den Chen: Innovator in Liver Disorder Therapies
Introduction
Kuang-Den Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of liver disorders. With a total of 2 patents, his work focuses on improving treatment outcomes for patients suffering from hepatitis C.
Latest Patents
Chen's latest patents include groundbreaking methods for predicting a subject's responsiveness to therapy for liver disorders. One of his notable inventions is a set of nucleic acids that can predict how well a patient will respond to treatment. Another important patent involves a method for detecting an individual's propensity to respond effectively to a combined therapy of interferon-α and ribavirin. This invention provides isolated polynucleotides that include sequences from the genomic region around the gene CD81. These polynucleotides contain polymorphisms associated with treatment response in HCV patients and serve as valuable probes for screening potential responders to the therapy.
Career Highlights
Chen is currently associated with Vita Genomics, Inc., where he continues to advance his research and innovations. His work has been instrumental in developing new therapeutic strategies for liver disorders, showcasing his commitment to improving patient care.
Collaborations
Some of his notable coworkers include Yuchi Hwang and Jui-Lin Chen, who have collaborated with him on various research projects.
Conclusion
Kuang-Den Chen's contributions to the field of liver disorder therapies highlight his innovative spirit and dedication to medical research. His patents reflect a deep understanding of genetic factors influencing treatment responses, paving the way for more effective therapies for patients.